Event Type: Analysts/Investors Earning Call hosted by Systematix Institutional Equities to discuss Q1 FY27 financial results/performance
Date and Time: Friday, August 21, 2026 at 03:00 P.M. (IST)
Purpose: Discussion of financial results/performance for Quarter-I ended June 30, 2026 (Q1 FY27)
Timing Relative to Earnings: The call is scheduled after the quarter-end, specifically for discussing the already announced Q1 results
Management Participants:
Mr. Manish Dhanuka, Managing Director
Mr. Mridul Dhanuka, Whole Time Director
Mr. Sunil Kumar Gupta, Chief Financial Officer
Availability of Materials: The information will be hosted on the Company's website at www.orchidpharma.com
UPSI Disclosure: The document contains standard regulatory language but does not explicitly state that no unpublished price sensitive information will be shared
Additional Notes Section
Attachments: The invite of the Analysts/Investors Earning Call is enclosed with the disclosure
Financial Data Disclosure: No financial figures or performance data are included in this announcement - it is purely a scheduling notice
Logistical Details: The invitation includes multiple dial-in numbers for different locations:
Primary Number: +91 22 6280 1297
Secondary Number: +91 22 7115 8198
USA Toll Free: 1 866 746 2133
UK Toll Free: 0 808 101 1573
Singapore Toll Free: 800 101 2045
Hong Kong Toll Free: 800 964 448
Diamond Pass registration available at provided link for direct access
Regulatory References: Disclosure made pursuant to Regulation 30 read with Sub-Para 15, Para A of Part A of Schedule III of SEBI (LODR) Regulations, 2015, and SEBI Master Circular No. SEBI/HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026
Contact Information:
Vishal Manchanda, Equity Research Analyst (+91 97374 37148)
Mrunal Pawar, Senior VP & Group Head - Corporate Access & Corporate Communication (+91 22 6704 8088)
